TITLE

THROMBOLYSIS IN MYOCARDIAL INFARCTION, RESPONSE OF SERUM ENZYMES

AUTHOR(S)
Praetorius, F.; Kõrtge, P.
PUB. DATE
September 1966
SOURCE
Angiology;Sep1966, Vol. 17 Issue 9, p640
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Examines the response of serum enzymes on thrombolysis in myocardial infarction. Mathematical curve of the average Serum Glutamat Oxalat Transaminase and Serum Creatine Phosphokinase measurements; Effect of fibrinolytic therapy; Correlation of the findings with the results of Poliwada and colleagues' EKG investigation.
ACCESSION #
16378052

 

Related Articles

  • THE THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION. Poliwoda, Hubert // Angiology;Aug1966, Vol. 17 Issue 8, p528 

    Discusses the thrombolytic therapy of acute myocardial infarction. Recanalization of the thrombolitically narrowed or occluded coronary artery; Prevention of thrombosis in a functioning collateral circulation; Maintenance of the microcirculation in the outer zone of the infarction area.

  • The Efficacy Of Thrombolytic Treatment On Patients Who Are Above 75 Years Of Age. Keles, Telat; Akar, Nihal; Gürsel, Koray; Canbay, Alper; Sahin, Deniz; Durmaz, Tahir; Diker, Erdem; Aydogdu, Sinan // Internet Journal of Cardiology;2006, Vol. 3 Issue 1, p2 

    Background: For acute myocardial infarction (AMI) patients above the age of 75, the efficacy of thrombolytic treatment could not be demonstrated clearly. Recently, depending on the data obtained from observational studies, it has been advocated that thrombolytic treatment might not be showing...

  • An estimation of the efficiency of thrombolytic therapy in patients with myocardial infarction. Strelcenia, Margarita; Gubkin, S. V. // International Journal of Collaborative Research on Internal Medi;May2012, Vol. 4 Issue 5, p780 

    Introduction: Myocardial infarction (MI) is the most prognostic terrible disease. It is caused by the blockage of a coronary artery by a thrombus or clot. This is usually the result of a rupture of an atherosclerotic plaque within the artery. The heart muscle supplied by that artery is damaged...

  • Fibrinolytic Therapy Urokinase for Myocardial Infarction. Nakano, Minoru // Angiology;Oct1983, Vol. 34 Issue 10, p654 

    The article reports on fibrinolytic therapy urokinase (UK) for myocardial infarction. UK is believed to lyse thrombi appearing in the coronary artery and to prevent the extension of infarct by inhibiting the occurrence of secondary thrombi. The author has reported the results of previous studies...

  • IMPROVED LONG-TERM SURVIVAL FOLLOWING MYOCARDIAL INFARCTION WITH FIBRINOLYTIC THERAPY. Boyles, Paul W. // Angiology;Jun1965, Vol. 16 Issue 6, p346 

    1. Intravenous fibrinolytic therapy has no significant advantage over anticoagulants upon the immediate mortality associated with recent myocardial infarction. 2. Fibrinolytic and anticoagulant agents reduced the immediate mortality of patients with recent myocardial infarction compared to...

  • Microvascular perfusion 1 week and 6 months after myocardial infarction by first-pass perfusion cardiovascular magnetic resonance imaging. Bodi, V.; Sanchis, J.; López-Lereu, M. P.; Nüñez, J.; Sanz, R.; Palau, P.; Gómez, C.; Moratal, D.; Chorro, F. J.; Llácer, A. // Heart;Dec2006, Vol. 92 Issue 12, p1801 

    Objective: To characterise the evolution of myocardial perfusion during the first 6 months after myocardial infarction by first-pass perfusion cardiovascular magnetic resonance imaging (CMR) and determine its significance. Design: Prospective cohort design. Setting: Single-centre study in a...

  • Inducible ischemia after MI. Platzner, Anne; Saver, Barry // Journal of Family Practice;Nov1997, Vol. 45 Issue 5, p375 

    The article presents a study which examined the potential benefits of delayed revascularization after thrombolysis. Thrombolysis enhances the survival of acute myocardial infarction (AMI) patients. The delayed invasive therapy after thrombolysis for AMI minimizes the possibility of developing...

  • PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY IN THE RIGHT VENTRICLE MYOCARDIAL INFARCTION TREATMENT. Rafajlovski, Sašo; Orozović, Vjekoslav; Ristić-Anđelkov, Anđelka; Rađen, Goran // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Oct2005, Vol. 62 Issue 10, p731 

    Background/Aim. To present the results of percutaneous transluminal coronary angioplasty (PTCA) in the treatment of the patients with acute right ventricle myocardial infarction (ARVMI), with adjuvant analyses of the obtained results in the period of five years (2000-2004). Methodes....

  • Does Increased Lipoprotein (a) Impair the Effectiveness of Thrombolysis With Streptokinase? Tokgözoǧlu, S. Lale; Özmen, Ferhan; Kabukçu, Mehmet; Karanfil, Aydin; Aytemir, Kudret; Özkuyumcu, Cumhur; Ugurlu, Şevket // Angiology;Aug1995, Vol. 46 Issue 8, p727 

    Although lipoprotein (a) [Lp(a)] has been shown to interfere with thrombolysis in vitro, its effects on thrombolytic therapy in patients with acute myocardial infarction (MI) are not clear. The authors evaluated 32 male patients ages thirty-five to seventy-five (mean fifty-two ± ten) with the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics